Range Advisory’s Pfizer PFE Stock Holding History

Range Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Sell	8,891 -4,608	-34%	-$121K	0.03%	324
2026 Q1	$379K	Buy	+13,499	New	+$359K	0.07%	156

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Range Advisory's PFE Position: Q2 2026 in Review

Range Advisory reduced its Pfizer (PFE) stake by 34% in Q2 2026, selling an estimated $121K and leaving 8,891 shares worth $214K. The position accounts for 0.03% of the portfolio, ranked #324.

Range Advisory first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $379K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Range Advisory held 8,891 shares of Pfizer worth $214K as of Q2 2026.
Range Advisory sold 4,608 Pfizer shares in Q2 2026, an estimated $121K.
Pfizer made up 0.03% of Range Advisory's portfolio in Q2 2026, its #324 holding.
Range Advisory first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
Range Advisory's Pfizer position peaked at $379K in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Range Advisory's 13F filing for Q2 2026, filed 2 Sep 2026.